Acrocyte Therapeutics Inc.

Fremont, CA

UEI
WAKUBM87P2A4
CAGE
0QL75
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
46750 Fremont Blvd STE 110, Fremont, CA 94538, USA
Website
acrocyte.com
Founded
2020
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $2,653,048

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $2,653,048

Contract awards

Award Agency Obligated Awarded
Rapid and reliable autologous cell screening and expansion for organoid therapy 140D042690016 Interior Business Center (DO) $2,653,048

Quick answers

Is Acrocyte Therapeutics Inc. registered in SAM.gov?

Yes. Acrocyte Therapeutics Inc.'s SAM.gov registration is active through May 3, 2027.

How much has Acrocyte Therapeutics Inc. received in federal contracts?

Federal contracts obligated $2,653,048 to Acrocyte Therapeutics Inc. in fiscal years 2023 through 2027.

What is Acrocyte Therapeutics Inc.'s most recent federal award?

Acrocyte Therapeutics Inc.'s most recent federal contract award is Rapid and reliable autologous cell screening and expansion for organoid therapy (140D042690016), from Interior Business Center (DO), on March 19, 2026.

On GovTribe

See Acrocyte Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors